Abstract
The objective of this study was to evaluate the risk of malignancy (ROM) associated with atypia of undetermined significance (AUS) and suspicious follicular neoplasm (SFN) core needle biopsy (CNB) categories after further sub-classification. Data from 2267 thyroid nodules evaluated by ultrasound-guided CNB, from January to December 2015, were retrospectively reviewed. AUS nodules (n = 556) were sub-classified as follows: (1) architectural atypia (AUS-A; n = 369, 66.4%), (2) cytologic atypia (AUS-C; n = 35, 6.3%), (3) cytologic/architectural atypia (AUS-C/A; n = 85, 15.3%), or (4) oncocytic atypia (AUS-O; n = 67, 12.1%). SFN nodules (n = 172) were sub-classified as follows: (1) architectural atypia only (SFN-A; n = 110, 64%), (2) cytologic/architectural atypia (SFN-C/A; n = 24, 14%), or (3) oncocytic atypia (SFN-O; n = 38, 22%). Diagnostic surgery was performed in 162 (30.2%) AUS cases and 105 (61%) SFN cases. The ROM of each sub-category was evaluated. The overall ROM was 15.3–52.5% in AUS nodules and 35.5–58.1% in SFN nodules. The ROM was higher in the AUS-C (22.9–88.9%) and AUS-C/A (32.9–90.3%) groups than AUS-A (11.9–40%) and AUS-O (7.5–41.7%). In the SFN category, ROM in the SFN-C/A group was also higher than SFN-A or SFN-O (37.5–75%, 40–57.9%, and 21.1–47.1%, respectively). Our study shows that the ROM was higher in AUS or SFN sub-categories with cytologic atypia than those without cytologic atypia. Because of the heterogeneous nature of AUS and SFN categories, sub-classification may be a more effective approach for risk stratification, allowing optimal management of patients with thyroid nodules.
Similar content being viewed by others
References
Haugen BR (2017) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? Cancer 123:372–381
Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, Lim HK, Moon WJ, Na DG, Park JS, Choi YJ, Hahn SY, Jeon SJ, Jung SL, Kim DW, Kim EK, Kwak JY, Lee CY, Lee HJ, Lee JH, Lee JH, Lee KH, Park SW, Sung JY, Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology (2016) Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean society of thyroid radiology consensus statement and recommendations. Korean J Radiol 17:370–395
Cibas ES, Ali SZ (2009) The bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132:658–665
Baloch ZW, LiVolsi VA, Asa SL, et al. (2008) Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol 36:425–437
Stanley MW (2009) Thyroid cytology comes to Bethesda. Am J Clin Pathol 132:655–657
Renshaw AA (2011) Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: distinct patterns and associated risk of malignancy. Cancer Cytopathol 119:322–327
Renshaw AA (2010) Should “atypical follicular cells” in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol 118:186–189
Nayar R, Ivanovic M (2009) The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 national cancer institute thyroid fine needle aspiration state of the science conference. Cancer 117:195–202
VanderLaan PA, Marqusee E, Krane JF (2011) Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance. Am J Clin Pathol 136:572–577
Bongiovanni M, Krane JF, Cibas ES, Faquin WC (2012) The atypical thyroid fine-needle aspiration: past, present, and future. Cancer Cytopathol 120:73–86
Singh RS, Wang HH (2011) Eliminating the “Atypia of undetermined significance/follicular lesion of undetermined significance” category from the Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 136:896–902
Lim JXY, Nga ME, Chan DKH, Tan WB, Parameswaran R, Ngiam KY (2018) Subclassification of Bethesda atypical and follicular neoplasm categories according to nuclear and architectural atypia improves discrimination of thyroid malignancy risk. Thyroid 28:511–521
Williams MD, Suliburk JW, Staerkel GA, Busaidy NL, Clayman GL, Evans DB, Perrier ND (2009) Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. Ann Surg Oncol 16:3146–3153
Ustun B, Chhieng D, Van Dyke A, et al. (2014) Risk stratification in follicular neoplasm: a cytological assessment using the modified Bethesda classification. Cancer Cytopathol 122:536–545
Baek JH (2017) Current status of core needle biopsy of the thyroid. Ultrasonography 36:83–85
Jung CK, Baek JH (2017) Recent advances in core needle biopsy for thyroid nodules. Endocrinol Metab (Seoul) 32:407–412
Chung SR, Suh CH, Baek JH, Choi YJ, Lee JH (2018) The role of core needle biopsy in the diagnosis of initially detected thyroid nodules: a systematic review and meta-analysis. Eur Radiol 28:4909–4918
Lee YH, Baek JH, Jung SL, Kwak JY, Kim JH, Shin JH, Korean Society of Thyroid Radiology (KSThR), Korean Society of Radiology (2015) Ultrasound-guided fine needle aspiration of thyroid nodules: a consensus statement by the korean society of thyroid radiology. Korean J Radiol 16:391–401
Na DG, Kim JH, Sung JY, Baek JH, Jung KC, Lee H, Yoo H (2012) Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology. Thyroid 22:468–475
Jung CK, Min HS, Park HJ, Song DE, Kim JH, Park SY, Yoo H, Shin MK, Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group (2015) Pathology reporting of thyroid core needle biopsy: a proposal of the Korean endocrine pathology thyroid core needle biopsy study group. J Pathol Transl Med 49:288–299
Lloyd R, Osamura R, Klöppel G, Rosai J (2017) WHO classification of tumours of endocrine organs. 4th edn. Lyon: IARC
Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LDR, Barletta JA, Wenig BM, al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, el-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA (2016) Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2:1023–1029
Ho AS, Sarti EE, Jain KS, Wang H, Nixon IJ, Shaha AR, Shah JP, Kraus DH, Ghossein R, Fish SA, Wong RJ, Lin O, Morris LGT (2014) Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 24:832–839
Wu HH, Inman A, Cramer HM (2014) Subclassification of “atypia of undetermined significance” in thyroid fine-needle aspirates. Diagn Cytopathol 42:23–29
Valderrabano P, Khazai L, Thompson ZJ, Sharpe SC, Tarasova VD, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Wenig BM, Chung CH, Centeno BA, McIver B (2018) Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis. Thyroid 28:210–219
Ahn SH, Kim SD, Jeong WJ (2017) Comparison of risk of malignancy in a subgroup with atypia of undetermined significance/follicular lesion of undetermined significance: A meta-analysis. Head Neck 39:1699–1710
Valderrabano P, Khazai L, Thompson ZJ, Leon ME, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Wenig BM, Chung CH, Centeno BA, McIver B (2017) Cancer Risk Stratification of Indeterminate Thyroid Nodules: A Cytological Approach. Thyroid 27:1277–1284
Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, Paschke R, Valcavi R, Vitti P, AACE/ACE/AME Task Force on Thyroid Nodules (2016) American association of clinical endocrinologists, American college of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid Nodules 2016 Update. Endocr Pract 22:622–639
Baloch ZW, Cibas ES, Clark DP, Layfield LJ, Ljung BM, Pitman MB, Abati A (2008) The national cancer institute thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 5:6
Na DG, Baek JH, Jung SL, Kim JH, Sung JY, Kim KS, Lee JH, Shin JH, Choi YJ, Ha EJ, Lim HK, Kim SJ, Hahn SY, Lee KH, Choi YJ, Youn I, Kim YJ, Ahn HS, Ryu JH, Baek SM, Sim JS, Jung CK, Lee JH, Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology (2017) Core needle biopsy of the thyroid: 2016 consensus statement and recommendations from Korean society of thyroid radiology. Korean J Radiol 18:217–237
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This retrospective study was approved by the institutional review board. Informed consent was obtained from all patients prior to thyroid CNB.
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chung, S.R., Baek, J.H., Lee, J.H. et al. Risk of Malignancy According to the Sub-classification of Atypia of Undetermined Significance and Suspicious Follicular Neoplasm Categories in Thyroid Core Needle Biopsies. Endocr Pathol 30, 146–154 (2019). https://doi.org/10.1007/s12022-019-9577-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-019-9577-4